TheraRadar

Pharma Intelligence, Simplified

Landscape → CNS

Neuropathy

237 clinical trials

100 active
/
237 total (since 2015)
21
Phase 1 Active
46 total
53
Phase 2 Active
141 total
32
Phase 3 Active
64 total
11
Phase 4 Active
23 total

Top Sponsors (Industry)

Sorted by active Active Done Failed
argenx 6 2 0
Sanofi 3 0 0
Takeda 3 0 0
Immunovant Sciences GmbH 3 0 0
Dianthus Therapeutics 2 0 0
Qilu Pharmaceutical Co., Ltd. 2 0 0
WinSanTor, Inc 1 2 0
Alnylam Pharmaceuticals 1 1 0
Eli Lilly 1 1 0
Ionis Pharmaceuticals, Inc. 1 1 0
Octapharma 1 1 0
Johnson & Johnson 1 0 0
Kite, A Gilead Company 1 0 0
Life Biosciences Inc. 1 0 0
Kedrion S.p.A. 1 0 0
NCT06290128 RECRUITING
A Study to Test the Effects and Safety of Riliprubart in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) for Which the Usual Treatments do Not Work
Sanofi n=140
NCT07423390 RECRUITING
Study on the Efficacy and Safety of Mecobalamin in Preventing Taxane-related Peripheral Neuropathy
Qinghai Red Cross Hospital n=326
NCT06290141 RECRUITING
A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Sanofi n=160
NCT06858579 RECRUITING
A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)
Dianthus Therapeutics n=480
NCT06859099 ENROLLING BY INVITATION
Long-term Safety and Efficacy Study of Riliprubart in Participants With CIDP
Sanofi n=300
NCT06742190 RECRUITING
A Study to Assess the Efficacy and Safety of Empasiprubart Versus IVIg in Adults With Multifocal Motor Neuropathy
argenx n=115
NCT05327114 RECRUITING
Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Janssen Research & Development, LLC n=201
NCT07410169 NOT YET RECRUITING
Efficacy and Safety of Hyperbaric Oxygen Therapy in Improving Nab-paclitaxel-Induced Peripheral Neuropathy
Guangdong Provincial People's Hospital n=160
NCT07406854 ACTIVE NOT RECRUITING
A Phase 3, Multicenter, Randomized, Double-Masked, Sham-Controlled Clinical Trial for Leber's Hereditary Optic Neuropathy (LHON) Associated With ND4 Mutation
Wuhan Neurophth Biotechnology Limited Company n=95
NCT07091630 RECRUITING
A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP
argenx n=160
NCT06920004 RECRUITING
A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP
argenx n=218
NCT06747351 RECRUITING
A Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Takeda n=59
NCT07223203 RECRUITING
TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy
Alnylam Pharmaceuticals n=125
NCT06752356 RECRUITING
A Study Investigating Intravenous Human Normal Immune Globulin (IGIV) 10% in Subjects With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Kedrion S.p.A. n=161
NCT07287592 NOT YET RECRUITING
Glutamine for the Prophylaxis of Vincristine-induced Neuropathy in Children and Adolescents With Cancer.
Ain Shams University n=70
NCT05071300 ACTIVE NOT RECRUITING
A Study to Assess the Long-Term Safety and Efficacy of Eplontersen (Formerly Known as ION-682884, IONIS-TTR-LRx and AKCEA-TTR-LRx) in Patients With Hereditary Transthyretin-Mediated Amyloid Polyneuropathy
Ionis Pharmaceuticals, Inc. n=151
NCT05084053 ACTIVE NOT RECRUITING
A Study of TAK-771 in Japanese Participants With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) and Multifocal Motor Neuropathy (MMN)
Takeda n=26
NCT04715542 NOT YET RECRUITING
Stibium Metallicum Praeparatum 6x Versus Placebo in the Prevention of Paclitaxel-induced Peripheral Neurotoxicity
University of Bern n=120
NCT05136976 RECRUITING
Rituximab Therapy in Anti-Myelin Associated Glycoprotein Patients With Characteristics of Good Responders
Centre Hospitalier Universitaire de Saint Etienne n=90
NCT05397665 ACTIVE NOT RECRUITING
Pharmacodynamic EffIcacy and Clinical Benefit of AT 007 in Patients With Sorbitol Dehydrogenase (SORD) Deficiency
Applied Therapeutics, Inc. n=56
NCT04299893 RECRUITING
Ozone Therapy in Chemotherapy-induced Peripheral Neuropathy: RCT (O3NPIQ)
Bernardino Clavo, MD, PhD n=42
NCT06186479 RECRUITING
Clinical Trial With Aconite Pain Oil in Oncology Patients Under Chemotherapy to Prevent CIPN Grade-II, to Reduce Symptoms and to Improve the Quality of Life of Patients With CIPN
WALA Heilmittel GmbH n=350
NCT06994507 RECRUITING
GM1 Prophylaxis for Nab-paclitaxel-associated Chemotherapy-induced Peripheral Neuropathy (CIPN) in Patients With Breast Cancer
Qilu Pharmaceutical Co., Ltd. n=352
NCT04929236 RECRUITING
Study to Evaluate Safety and Efficacy of Different PANZYGA Dose Regimens in Pediatric Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) Patients
Octapharma n=30
NCT05624138 RECRUITING
The Possible Protective Role of Ketotifen Against Oxaliplatin Induced Peripheral Neuropathy
Tanta University n=64
NCT05786599 RECRUITING
Methadone to Treat Painful Chemotherapy Induced Peripheral Neuropathy
University of British Columbia n=50
NCT06858722 NOT YET RECRUITING
Ripertamab for the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy
Zhongming Qiu n=175
NCT06799351 RECRUITING
Gut Microbiome Profiles in Patients with Chemotherapy-induced Neuropathy in the RCT OzoParQT (NCT06706544).
Bernardino Clavo, MD, PhD n=42
NCT06706544 RECRUITING
Ozone Treatment in Paresthesia (Numbness, Tingling) Secondary to Chemotherapy-induced Peripheral Neuropathy
Bernardino Clavo, MD, PhD n=42
NCT05840562 RECRUITING
Capsaicin 179 mg Patch Versus Oral Duloxetine in Patients With Chemotherapy-induced Peripheral Neuropathy
Institut Cancerologie de l'Ouest n=274
NCT06513533 RECRUITING
Dimethyl Fumarate in Adrenomyeloneuropathy
Pujol, Aurora, M.D. n=40
NCT04912843 RECRUITING
Gene Therapy Clinical Trial for the Treatment Of Leber's HereDitary Optic Neuropathy
Wuhan Neurophth Biotechnology Limited Company n=102
NCT03406104 COMPLETED
RESCUE and REVERSE Long-term Follow-up
GenSight Biologics n=62
NCT06715462 WITHDRAWN
Efficacy and Safety of the N0750 Compared to Monotherapies in the Treatment of Painful Diabetic Peripheral Neuropathy
Eurofarma Laboratorios S.A.
NCT04873232 COMPLETED
A 6-Month Extension Study of VMDN-003-2 to Assess Engensis in Participants With Painful Diabetic Peripheral Neuropathy
Helixmith Co., Ltd. n=106
NCT05680870 COMPLETED
The Possible Protective Role of Omeprazole Against Oxaliplatin Induced Neuropathy in Cancer Patients
Aya Mohamed Sadek Elsaid n=46
NCT03293524 COMPLETED
Efficacy & Safety Study of Bilateral IVT Injection of GS010 in LHON Subjects Due to the ND4 Mutation for up to 1 Year
GenSight Biologics n=98
NCT02936843 COMPLETED
Targeting Inflammation With Salsalate in Type 1 Diabetes Neuropathy
University of Michigan n=61
NCT05281562 TERMINATED
Immunonutrition for Diabetic Foot Ulcers
Prisma Health-Midlands n=1
NCT04136184 COMPLETED
NEURO-TTRansform: A Study to Evaluate the Efficacy and Safety of Eplontersen (Formerly Known as ION-682884, IONIS-TTR-LRx and AKCEA-TTR-LRx) in Participants With Hereditary Transthyretin-Mediated Amyloid Polyneuropathy
Ionis Pharmaceuticals, Inc. n=168
NCT04418024 WITHDRAWN
Efficacy and Safety of AG10 in Subjects with Transthyretin Amyloid Polyneurophathy
Eidos Therapeutics, a BridgeBio company
NCT04882735 WITHDRAWN
Efficacy and Safety of Acoramidis (AG10) in Subjects with Transthyretin Amyloid Polyneurophathy (ATTRibute-PN)
Eidos Therapeutics, a BridgeBio company
NCT03747562 WITHDRAWN
Study of Efficacy and Safety of Gabapentin to Reduce the Need for Strong Opioid Use in Head and Neck Cancer Patients.
University Hospital, Ghent
NCT02955355 COMPLETED
Long-Term Tolerability and Safety of HYQVIA/HyQvia in CIDP
Baxalta now part of Shire n=85
NCT06325943 COMPLETED
Rituximab in Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Istituto Clinico Humanitas n=37
NCT03308448 COMPLETED
Traumatic Optic Neuropathy Treatment Trial 2
Iran University of Medical Sciences n=93
NCT05189535 COMPLETED
"Prevention of Paclitaxel-Induced Peripheral Neuropathy in Breast Cancer Patients"
Ain Shams University n=66
NCT05619328 COMPLETED
A Prospective Clinical Trial to Evaluate the Efficacy and Safety of Neurotropic B-Vitamins in Clinically Diagnosed Peripheral Sensory Polyneuropathy of Different Etiologies.
Procter and Gamble n=323
NCT04647877 COMPLETED
Phenytoin Cream for the Treatment of Neuropathic Pain
David J. Kopsky n=81
NCT02549170 COMPLETED
A Study of HyQvia and Gammagard Liquid (Kiovig) in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Baxalta now part of Shire n=138
NCT03555916 COMPLETED
Botulinum Toxin Injections for Oral Neuropathic Pain
Assistance Publique - Hôpitaux de Paris n=43
NCT05567081 COMPLETED
Efficacy of Ultrasound-Guided PRP Versus Corticosteroid Injection in Patients With Ulnar Neuropathy at Elbow
Tanta University n=60
NCT04303416 COMPLETED
Plasma Exchange With Albumin in AMN Patients
Pujol, Aurora, M.D. n=5
NCT05319275 COMPLETED
Study of Acetyllevocarnitine Hydrochloride Tablets in Chinese Patients With Paresthesias Caused by DPN
Haisco Pharmaceutical Group Co., Ltd. n=516
NCT04034355 TERMINATED
Preventive Treatment of OxaLiplatin Induced peripherAl neuRopathy in Adjuvant Colorectal Cancer
Egetis Therapeutics n=301
NCT03654729 TERMINATED
Preventive Treatment of Oxaliplatin Induced Peripheral Neuropathy in Metastatic Colorectal Cancer (POLAR-M)
Egetis Therapeutics n=291
NCT04877067 COMPLETED
Therapy of Toxic Optic Neuropathy Via Combination of Stem Cells With Electromagnetic Stimulation
Ankara Universitesi Teknokent n=18
NCT02317562 TERMINATED
Efficacy and Safety Study of I10E in the Maintenance Treatment of Patients With CIDP: Extension of PRISM Study I10E-1302
Laboratoire français de Fractionnement et de Biotechnologies n=19
NCT02638207 COMPLETED
Study to Evaluate Safety and Efficacy of Three Different Dosages of NewGam in Patients With Chronic Inflammatory Demyelinating Poly (Radiculo) Neuropathy
Octapharma n=142
NCT02293460 COMPLETED
Efficacy and Safety Study of I10E in Treatment of Patients With CIDP
Laboratoire français de Fractionnement et de Biotechnologies n=44
NCT02341560 TERMINATED
Phase 2/3, Randomized, Double-Masked, Sham-Controlled Trial of QPI-1007 in Subjects With Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
Quark Pharmaceuticals n=732
NCT03221907 COMPLETED
Clinical Trial to Evaluate the Efficacy and Safety of 'GLA5PR GLARS-NF1 Tab.' in Peripheral Neuropathic Pain
Daewon Pharmaceutical Co., Ltd. n=352
NCT02281656 COMPLETED
Prospective Evaluation of Reverse End to Side Anterior Interosseous Nerve to Ulnar Nerve Transfer for Severe Compressive Ulnar Neuropathy at the Elbow
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's n=40
NCT02141035 COMPLETED
Acetyl-l-carnitine to Enhance Nerve Regeneration in Carpal Tunnel Syndrome
University of Alberta n=20

Data: ClinicalTrials.gov